Answers are grounded in this paper and cite their sources.
The very low organism burdens of fungi causing infection have previously prevented direct culture and detection of antifungal resistance in clinical samples. These findings have major implications for the sustainability of triazoles for human antifungal therapy.
No takes yet. Share an insight, caveat, or question.
Denning et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: